This New Weight Loss Shot Isn’t a GLP-1 (20% in 48 Weeks) #metabolichealth #glp1

Text (720) 726-1792 to get started today!
A new weight-loss medication is making headlines-and it isn’t another GLP-1. Cagrilintide works through the amylin pathway, a different fullness signal your body naturally produces after eating. Here’s what the early research shows, how it compares with today’s leading weight-loss medications, and why lasting results still depend on your metabolic foundation.

Share on: